Author

M.J. Petrus

Observed name: Matthew J. Petrus

Institutions: National Institutes of Health, National Cancer Institute

Observed institutions: National Institutes of Health, National Cancer Institute

OpenAlex ID: A5111591999

An immunoablative regimen of fludarabine and cyclophosphamide prevents fully MHC-mismatched murine marrow graft rejection independent of GVHD

2000 · Matthew J. Petrus, Jonathan F. Williams, et al. · Transplantation and Cellular Therapy · 37

Selection and expansion of T cells from untreated patients with CLL: source of cells for immune reconstitution?

2000 · A. Husebekk, V. Fellowes, et al. · Cytotherapy · 4

Works count: 2

Citation count: 41

H-index: 2

I10-index: 1